Accessibility to Healthcare and Risk of Polypharmacy on Chronically ill Patients

Basit Öğe Kaydı
dc.authoridengin, velittin selcuk/0000-0002-6338-4748
dc.authoridErsoy, Suleyman/0000-0003-0001-9329
dc.contributor.authorErsoy, Suleyman
dc.contributor.authorEngin, Velittin Selcuk
dc.date.accessioned2024-09-29T16:07:49Z
dc.date.available2024-09-29T16:07:49Z
dc.date.issued2019
dc.departmentKarabük Üniversitesien_US
dc.description.abstractObjective: To investigate the rates of polypharmacy (PP) and its relations with accessibility to health services in chronic patients in a primary care setting. Study Design: A cross-sectional study. Place and Duration of Study: Melekhatun Family Health Center, Istanbul, Turkey, from January 2014 to January 2017. Methodology: Chronically ill older adults were enrolled in the study. Patients were seen either at home or at health centre. Threshold for PP was five medications daily. Chi-square tests were applied for group comparisons of PP. Continuous variables were examined by Student's t-test. Logistic regressions followed. Results: Study population (n= 707) consisted of 442 female (62.5%) and 265 male (37.5%) subjects. Mean age was 73.6 +/- 7.1 years. Mean number of medicine used per day was 4.7 +/- 3.5. Polypharmacy rate was 32.8%. Although the number of chronic diseases, that at home patients had, was significantly higher, outpatients had 1.92 times higher risk for PP. Similarly, risk for PP was found 2.57-fold higher in insured patients. Conclusion: Univariate results of this study suggests that accessibility to health services also increases PP risk, in addition to known risk factors such as female gender, depression and chronic diseases. Same results draw our attention to the risk of inadequate treatment in those who lack health insurance. Longitudinal studies in larger scale are needed for further assessment of these relationships.en_US
dc.identifier.doi10.29271/jcpsp.2019.06.505
dc.identifier.endpage510en_US
dc.identifier.issn1022-386X
dc.identifier.issn1681-7168
dc.identifier.issue6en_US
dc.identifier.pmid31133145en_US
dc.identifier.scopus2-s2.0-85066936125en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage505en_US
dc.identifier.urihttps://doi.org/10.29271/jcpsp.2019.06.505
dc.identifier.urihttps://hdl.handle.net/20.500.14619/7197
dc.identifier.volume29en_US
dc.identifier.wosWOS:000469251800005en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherColl Physicians & Surgeons Pakistanen_US
dc.relation.ispartofJcpsp-Journal of the College of Physicians and Surgeons Pakistanen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectChronic patienten_US
dc.subjectPolypharmacyen_US
dc.subjectComprehensive geriatric assessmenten_US
dc.subjectMedical insuranceen_US
dc.subjectHomebound patienten_US
dc.titleAccessibility to Healthcare and Risk of Polypharmacy on Chronically ill Patientsen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu

We collect and process your personal information for the following purposes: Authentication, Preferences, Acknowledgement and Statistics.
To learn more, please read our privacy policy.

Customize